This invention belongs to the fields of
organic chemistry,
medicinal chemistry, and
pharmacology, specifically relating to the synthesis of lometapeptide bioelectron isosteres and their application in the preparation of therapeutic drugs for lipid-lowering diseases. A method for preparing lometapeptide bioelectron isosteres mainly includes six steps: 1) Using A and B as starting materials, under
nickel catalysis and the action of
phosphine ligands, a reaction occurs... endo The reaction [2+2] yielded intermediate I; 2) Intermediate I underwent
intramolecular cyclization under thioxanthracene-9-one and
photocatalysis to yield intermediate II; 3) Intermediate II was oxidized under alkaline
potassium permanganate to yield intermediate III; 4) Intermediate III and C reacted under the action of a condensing agent to prepare
amide intermediate IV; 5) Intermediate IV was debenzylated under the action of
palladium on carbon and a
hydrogen source to prepare amine intermediate V; 6) Intermediate V and D under alkaline conditions underwent a
substitution reaction to obtain the final product, lometapetine bioelectron
isostere VI. This bioelectron
isostere can
dose-dependently inhibit the
secretion of
apolipoprotein B in HepG2 cells and exhibits good kinetic
solubility. This compound shows promise for development as a therapeutic
drug for hypercholesterolemia-related diseases.